CME Group’s (CME) Sell Rating Reaffirmed at Rosenblatt Securities

Rosenblatt Securities restated their sell rating on shares of CME Group (NASDAQ:CME) in a research report released on Thursday morning, Benzinga reports. They currently have a $187.00 target price on the financial services provider’s stock, up from their previous target price of $185.00.

Other research analysts have also issued reports about the company. The Goldman Sachs Group lowered CME Group from a neutral rating to a sell rating and set a $195.00 price target for the company. in a report on Wednesday, January 3rd. Keefe, Bruyette & Woods restated a market perform rating and issued a $229.00 target price on shares of CME Group in a research note on Wednesday, April 3rd. Argus upped their price target on CME Group from $225.00 to $245.00 and gave the company a buy rating in a research report on Wednesday, March 6th. Barclays upped their price target on CME Group from $225.00 to $226.00 and gave the company an equal weight rating in a research report on Monday, April 8th. Finally, Deutsche Bank Aktiengesellschaft reiterated a hold rating and issued a $210.00 price target (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of Hold and an average price target of $217.80.

CME Group Trading Down 0.0 %

NASDAQ:CME opened at $212.54 on Thursday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group has a fifty-two week low of $175.73 and a fifty-two week high of $223.80. The stock’s 50-day moving average is $214.76 and its two-hundred day moving average is $211.93. The stock has a market cap of $76.51 billion, a PE ratio of 24.18, a price-to-earnings-growth ratio of 5.97 and a beta of 0.49.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter in the previous year, the business posted $2.42 EPS. The firm’s quarterly revenue was up 3.2% compared to the same quarter last year. As a group, equities research analysts forecast that CME Group will post 9.58 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were paid a $1.15 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.16%. CME Group’s dividend payout ratio is presently 52.33%.

Institutional Investors Weigh In On CME Group

Several institutional investors have recently bought and sold shares of the company. Mesirow Financial Investment Management Inc. acquired a new position in shares of CME Group during the 1st quarter worth approximately $2,575,000. MONECO Advisors LLC increased its holdings in shares of CME Group by 10.1% during the 1st quarter. MONECO Advisors LLC now owns 1,186 shares of the financial services provider’s stock worth $255,000 after acquiring an additional 109 shares during the last quarter. Checchi Capital Advisers LLC increased its holdings in shares of CME Group by 4.5% during the 1st quarter. Checchi Capital Advisers LLC now owns 5,421 shares of the financial services provider’s stock worth $1,167,000 after acquiring an additional 231 shares during the last quarter. Bogart Wealth LLC increased its holdings in shares of CME Group by 48.7% during the 1st quarter. Bogart Wealth LLC now owns 58,266 shares of the financial services provider’s stock worth $12,544,000 after acquiring an additional 19,075 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in shares of CME Group by 2.9% during the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock worth $1,462,678,000 after acquiring an additional 189,842 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.